Commentary urges consistent scrutiny of COVID-19, vaccination and cancer links

A commentary published in the journal Oncotarget argues that scientific assessments of possible links between COVID-19 infection, COVID-19 vaccination and cancer should apply consistent evidentiary standards, whether findings implicate infection, vaccination or both. The article, authored by independent researcher Raphael Lataster at the University of Sydney, responds to a recent Oncotarget review by Charlotte Kuperwasser and Wafik S. El-Deiry examining published reports concerning cancer following COVID-19 infection or vaccination. Published on September 11, 2026, in Volume 17 of the journal, the commentary calls for further investigation of potential associations rather than establishing a causal relationship between COVID-19 vaccination and cancer.

Lataster’s central argument concerns the evaluation of evidence rather than the presentation of a new epidemiological result. The commentary reviews research about potential associations between COVID-19 and cancer, including mechanisms proposed in the literature, and argues that mechanisms reported in connection with COVID-19 vaccination warrant consideration and further study. The author also highlights differences in how evidence concerning COVID-19 vaccines and cancer has been assessed in the scientific literature. “Such inquiries should proceed without preconceptions, applying the same evidentiary standards regardless of whether findings implicate infection, vaccination, or both,” the commentary says.

The distinction between an association and a causal relationship is explicit in the commentary. According to the report, Lataster does not establish that COVID-19 vaccination causes cancer. Instead, he calls for potential associations and biological mechanisms to be investigated without predetermined conclusions, while giving appropriate consideration to alternative explanations and the limitations of observational evidence. The commentary therefore raises a research question and identifies an issue in the consistency of scientific evaluation; it does not report new evidence showing that vaccination increases cancer risk, protects against cancer, or accounts for a particular proportion of cancer cases.

Because this is a commentary, its contribution is an argument about how evidence concerning infection, vaccination and cancer should be considered. Its discussion draws on published work concerning COVID-19 and cancer and responds to the earlier Oncotarget review. The article does not provide a new epidemiologic analysis of trial, cohort or case-control data. Its proposed contribution is to prompt further investigation and comparison under equivalent evidentiary conditions, with explicit attention to alternative explanations and the limitations of observational findings. In that sense, the commentary supports a more consistent line of inquiry without supplying a new causal conclusion about COVID-19, vaccination and cancer.

Subject of Research: Evaluation of proposed associations among COVID-19 infection, COVID-19 vaccination and cancer

Article Title: Commentary calls for consistent evaluation of potential links between COVID-19, vaccination and cancer

Article References: Commentary calls for consistent evaluation of potential links between COVID-19, vaccination and cancer. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: COVID-19, COVID-19 vaccines, cancer, research standards, observational evidence, causal relationship, Oncotarget, commentary, calls, consistent, evaluation, potential